Edwards Lifesciences stock after-hours at EUR 77.53: plus 2.43 percent versus prior close
Published on 10/05/2026 at 18:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edwards Lifesciences traded at EUR 77.53 after-hours at 5:56 p.m. CEST on October 5, 2026, up 2.43 percent versus the prior close of EUR 75.69 at Lang & Schwarz.
Trading session
The Lang & Schwarz bid was EUR 77.42 and the ask was EUR 77.64. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Edwards Lifesciences stock.
Investor event planned for November
Edwards Lifesciences announced on October 5 that it will host an investor event in conjunction with the TCT annual scientific symposium in San Diego on November 2, 2026, from 5:00 to 6:00 p.m. Pacific Time. The event will include a live question-and-answer session with physicians and members of the Edwards management team. A live webcast and an archived version will be available through the company’s investor relations website, according to Business Wire.
AUTUS valve receives FDA approval
In a release dated October 1, Edwards Lifesciences said the FDA had approved its AUTUS Size-Adjustable Valve, a surgical pulmonary valve designed for pediatric patients with congenital heart disease. The company said the valve can be expanded as a child grows through a minimally invasive transcatheter procedure. The approval was based on clinical evidence from a pivotal study, according to Edwards Lifesciences.
